FDAnews
www.fdanews.com/articles/125969-eli-lilly-fda-still-reviewing-cymbalta-for-chronic-pain

Eli Lilly: FDA Still Reviewing Cymbalta for Chronic Pain

April 6, 2010
Indianapolis-based Eli Lilly & Co. said U.S. regulators are still reviewing its application for an additional use of the antidepressant Cymbalta for chronic pain.
IndyStar